消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2020 ESPEN实践指南：肝病的临床营养

2020-12-03 欧洲临床营养和代谢学会 Clin Nutr . 2020 Dec;39(12):3533-3562.

肝病

2020年12月，欧洲临床营养和代谢学会(ESPEN)发布了肝病的临床营养指南，该指南针对肝病的临床营养共形成了103条陈述和建议，内容设计急性肝衰竭、酒精性脂肪性肝炎，非酒精性脂肪性肝病、肝硬化以及

中文标题：

2020 ESPEN实践指南：肝病的临床营养

英文标题：

ESPEN practical guideline: Clinical nutrition in liver disease

发布机构：

欧洲临床营养和代谢学会

发布日期：

2020-12-03

简要介绍：

2020年12月，欧洲临床营养和代谢学会(ESPEN)发布了肝病的临床营养指南，该指南针对肝病的临床营养共形成了103条陈述和建议，内容设计急性肝衰竭、酒精性脂肪性肝炎，非酒精性脂肪性肝病、肝硬化以及肝脏手术/移植患者的营养和代谢管理。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESPEN实践指南：肝病的临床营养.pdf)] GetToolGuiderByIdResponse(projectId=1, id=af1231c00202ea19, title=2020 ESPEN实践指南：肝病的临床营养, enTitle=ESPEN practical guideline: Clinical nutrition in liver disease, guiderFrom=Clin Nutr . 2020 Dec;39(12):3533-3562., authorId=0, author=, summary=2020年12月，欧洲临床营养和代谢学会(ESPEN)发布了肝病的临床营养指南，该指南针对肝病的临床营养共形成了103条陈述和建议，内容设计急性肝衰竭、酒精性脂肪性肝炎，非酒精性脂肪性肝病、肝硬化以及, cover=https://img.medsci.cn/20201220/1608394251630_2020535.jpg, journalId=0, articlesId=null, associationId=374, associationName=欧洲临床营养和代谢学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Dec 03 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月，欧洲临床营养和代谢学会(ESPEN)发布了肝病的临床营养指南，该指南针对肝病的临床营养共形成了103条陈述和建议，内容设计急性肝衰竭、酒精性脂肪性肝炎，非酒精性脂肪性肝病、肝硬化以及肝脏手术/移植患者的营养和代谢管理。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=835, tagName=肝病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=835, guiderKeyword=肝病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12959, appHits=321, showAppHits=0, pcHits=1149, showPcHits=12638, likes=3, shares=36, comments=23, approvalStatus=1, publishedTime=Sun Dec 20 00:15:40 CST 2020, publishedTimeString=2020-12-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 20 00:10:58 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 08:54:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESPEN实践指南：肝病的临床营养.pdf)])
2020 ESPEN实践指南：肝病的临床营养.pdf
下载请点击：
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2127033, encodeId=06bc212e03373, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f076405107, createdName=ms2000001680053118, createdTime=Wed Apr 19 15:17:10 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191125, encodeId=a4c611911257f, content=知识面广，有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:14:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059890, encodeId=aa031059890b4, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq65GoIzj6QEruzBIUHx2tCkhjEYh6ZicZ3hhk4eclxR6POmDmnZp5FrMNAckgXER39xhZiaSkh7uDA/132, createdBy=21f05248050, createdName=大白9968, createdTime=Tue Oct 12 18:34:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005330, encodeId=c8351005330b4, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51855415230, createdName=ms6000000120954212, createdTime=Thu Aug 05 11:52:23 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996628, encodeId=50d7996628de, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/fd1465083331408bbd6f67c60a9b1cb4/d3b2eba861f54e7987ad033710ceb5ee.jpg, createdBy=f01e5539280, createdName=ms5000001565343130, createdTime=Mon Jul 05 23:51:39 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2023-04-19 ms2000001680053118 来自广东省

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2127033, encodeId=06bc212e03373, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f076405107, createdName=ms2000001680053118, createdTime=Wed Apr 19 15:17:10 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191125, encodeId=a4c611911257f, content=知识面广，有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:14:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059890, encodeId=aa031059890b4, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq65GoIzj6QEruzBIUHx2tCkhjEYh6ZicZ3hhk4eclxR6POmDmnZp5FrMNAckgXER39xhZiaSkh7uDA/132, createdBy=21f05248050, createdName=大白9968, createdTime=Tue Oct 12 18:34:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005330, encodeId=c8351005330b4, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51855415230, createdName=ms6000000120954212, createdTime=Thu Aug 05 11:52:23 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996628, encodeId=50d7996628de, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/fd1465083331408bbd6f67c60a9b1cb4/d3b2eba861f54e7987ad033710ceb5ee.jpg, createdBy=f01e5539280, createdName=ms5000001565343130, createdTime=Mon Jul 05 23:51:39 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2022-02-08 ms3000000637975859

    知识面广，有价值

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2127033, encodeId=06bc212e03373, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f076405107, createdName=ms2000001680053118, createdTime=Wed Apr 19 15:17:10 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191125, encodeId=a4c611911257f, content=知识面广，有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:14:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059890, encodeId=aa031059890b4, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq65GoIzj6QEruzBIUHx2tCkhjEYh6ZicZ3hhk4eclxR6POmDmnZp5FrMNAckgXER39xhZiaSkh7uDA/132, createdBy=21f05248050, createdName=大白9968, createdTime=Tue Oct 12 18:34:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005330, encodeId=c8351005330b4, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51855415230, createdName=ms6000000120954212, createdTime=Thu Aug 05 11:52:23 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996628, encodeId=50d7996628de, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/fd1465083331408bbd6f67c60a9b1cb4/d3b2eba861f54e7987ad033710ceb5ee.jpg, createdBy=f01e5539280, createdName=ms5000001565343130, createdTime=Mon Jul 05 23:51:39 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-10-12 大白9968

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2127033, encodeId=06bc212e03373, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f076405107, createdName=ms2000001680053118, createdTime=Wed Apr 19 15:17:10 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191125, encodeId=a4c611911257f, content=知识面广，有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:14:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059890, encodeId=aa031059890b4, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq65GoIzj6QEruzBIUHx2tCkhjEYh6ZicZ3hhk4eclxR6POmDmnZp5FrMNAckgXER39xhZiaSkh7uDA/132, createdBy=21f05248050, createdName=大白9968, createdTime=Tue Oct 12 18:34:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005330, encodeId=c8351005330b4, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51855415230, createdName=ms6000000120954212, createdTime=Thu Aug 05 11:52:23 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996628, encodeId=50d7996628de, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/fd1465083331408bbd6f67c60a9b1cb4/d3b2eba861f54e7987ad033710ceb5ee.jpg, createdBy=f01e5539280, createdName=ms5000001565343130, createdTime=Mon Jul 05 23:51:39 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-08-05 ms6000000120954212

    非常实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2127033, encodeId=06bc212e03373, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f076405107, createdName=ms2000001680053118, createdTime=Wed Apr 19 15:17:10 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1191125, encodeId=a4c611911257f, content=知识面广，有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:14:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059890, encodeId=aa031059890b4, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq65GoIzj6QEruzBIUHx2tCkhjEYh6ZicZ3hhk4eclxR6POmDmnZp5FrMNAckgXER39xhZiaSkh7uDA/132, createdBy=21f05248050, createdName=大白9968, createdTime=Tue Oct 12 18:34:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005330, encodeId=c8351005330b4, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51855415230, createdName=ms6000000120954212, createdTime=Thu Aug 05 11:52:23 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996628, encodeId=50d7996628de, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/fd1465083331408bbd6f67c60a9b1cb4/d3b2eba861f54e7987ad033710ceb5ee.jpg, createdBy=f01e5539280, createdName=ms5000001565343130, createdTime=Mon Jul 05 23:51:39 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-05 ms5000001565343130

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2019 ESPEN指南：肝病临床营养

欧洲临床营养和代谢学会(ESPEN,The European Society for Clinical Nutrition and Metabolism) · 2019-01-16

多烯磷脂酰胆碱在肝病临床应用的专家共识

中国肝病科相关专家小组（统称） · 2017-08-30

非酒精性脂肪性肝病的治疗—欧洲肥胖-2型糖尿病-消化临床实践指南解读

暂未更新 · 2017-05-30

《2016年北美儿童胃肠病肝病营养学会临床实践指南：儿童脂肪性肝病的诊断治疗》摘译

暂未更新 · 2017-04-09

2016 甘草酸制剂肝病临床应用专家共识

中国肝病科相关专家小组（统称） · 2016-02-01

2016 EASL/EASD/EASO临床实践指南：非酒精性脂肪性肝病的管理

欧洲糖尿病研究协会(EASD,European Association for the Study of Diabetes) · 2016-04-08

拓展阅读

胆汁淤积性肝病诊断治疗专家共识2013

胆汁淤积性肝病诊断治疗专家委员会 · 2013-01-01

2014 WGO全球指南：非酒精性脂肪性肝病和非酒精性脂肪性肝炎诊疗指南

世界胃肠病学组织(WGO,World Gastroenterology Organisation) · 2014-07-06

2015 CASL共识指南：慢性丙型肝炎的管理（更新版）

加拿大肝病学会(CASL,Cannadian Association for the Study of the Liver) · 2015-01-13

胆汁淤积性肝病诊断和治疗共识(2015)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-04-27

甘草酸制剂肝病临床应用专家共识 2016

暂未更新 · 2016-06-08

2016 EASL/EASD/EASO临床实践指南：非酒精性脂肪性肝病的管理

欧洲糖尿病研究协会(EASD,European Association for the Study of Diabetes) · 2016-04-08